Fort Myers, Florida - March 04, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational ...

Purepac Pharmaceutical, a subsidiary of Fort Lee generic pharmaceutical company Alpharma (NYSE: ALO), has received final approval from the Food and Drug Administration to market gabapentin tablets–a ...

300mg once on day 1, twice daily on day 2, and 3 times daily on day 3; may titrate up to usual max 1.8g/day in 3 divided doses (doses up to 3.6g/day have been used without added benefit). Renal ...

Receiving six or more prescriptions of the drug gabapentin for low back pain is associated with significantly increased risks of developing dementia and mild cognitive impairment (MCI)--29% and 85%, ...

His CT, EEG and MRI were negative. He had been taking gabapentin for four years with a current dosage of 1,800 mg daily. When this was stopped, he immediately began regaining his cognition and was ...

Though increasingly prescribed in the U.S., a 2025 study linked gabapentin prescriptions for chronic low back pain with ...

Gabapentin is an FDA-approved prescription anticonvulsant that is primarily used to treat nerve pain and control epileptic seizures. But it is also prescribed "off-label" as a painkiller or treatment ...

Gabapentin has been approved in the United States for the treatment of epilepsy and postherpetic neuralgia. Gabapentin has also demonstrated proven efficacy for the treatment of diabetic peripheral ...

MUMBAI, Nov 16 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd is recalling some gabapentin tablets in the United States, a spokesman said, confirming a report in the Economic Times on Friday.

Neurontin (Gabapentin) is an anticonvulsant medication that is also used to treat nerve pain. The FDA-approved pill is a non-narcotic medication thought by experts to have a low abuse profile. RELATED ...

Gabapentin has many drug interactions, and a new drug might have increased the blood level. Gabapentin is also dependent on kidney function. Any change in kidney function from not ...